NASDAQ: NKTR Long Term Investor Alert: Investigation of Potential Wrongdoing at Nektar Therapeutics
January 29, 2020 at 13:00 PM EST
San Diego, CA -- (SBWIRE) -- 01/29/2020 -- Certain directors of Nektar Therapeutics are under investigation on behalf of current long-term investors in shares of Nektar Therapeutics (NASDAQ: NKTR) concerning potential breaches of fiduciary duties by certain directors and officers of Nektar Therapeutics was announced.
